FKBP25, a novel regulator of the p53 pathway, induces the degradation of MDM2 and activation of p53

Anna Maria Ochocka, Petros Kampanis, Samantha Nicol, Nerea Allende-Vega, Miranda Cox, Lynnette Marcar, Diane Milne, Frances Fuller-Pace, David Meek

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

The p53 tumour suppressor protein is tightly controlled by the E3 ubiquitin ligase, mouse double minute 2 (MDM2), but maintains MDM2 expression as part of a negative feedback loop. We have identified the immunophilin, 25kDa FK506-binding protein (FKBP25), previously shown to be regulated by p53-mediated repression, as an MDM2-interacting partner. We show that FKBP25 stimulates auto-ubiquitylation and proteasomal degradation of MDM2, leading to the induction of p53. Depletion of FKBP25 by siRNA leads to increased levels of MDM2 and a corresponding reduction in p53 and p21 levels. These data are consistent with the idea that FKBP25 contributes to regulation of the p53-MDM2 negative feedback loop.

Original languageEnglish
Pages (from-to)621-6
Number of pages6
JournalFEBS Letters
Volume583
Issue number4
DOIs
Publication statusPublished - 18 Feb 2009

Keywords / Materials (for Non-textual outputs)

  • Animals
  • Cell Line, Tumor
  • Cyclin-Dependent Kinase Inhibitor p21
  • Escherichia coli
  • Gene Expression Regulation, Neoplastic
  • Genes, Reporter
  • Glutathione Transferase
  • HCT116 Cells
  • Humans
  • Luciferases
  • Mice
  • Proteasome Endopeptidase Complex
  • Proto-Oncogene Proteins c-mdm2
  • RNA, Small Interfering
  • Recombinant Fusion Proteins
  • Tacrolimus Binding Proteins
  • Transfection
  • Tumor Suppressor Protein p53
  • Ubiquitin-Protein Ligases
  • Ubiquitination

Fingerprint

Dive into the research topics of 'FKBP25, a novel regulator of the p53 pathway, induces the degradation of MDM2 and activation of p53'. Together they form a unique fingerprint.

Cite this